Remi Gaston-Dreyfus - 13 Jun 2023 Form 4 Insider Report for Bionik Laboratories Corp. (BNKL)

Role
Director, 10%+ Owner
Signature
/s/ Remi Gaston-Dreyfus
Issuer symbol
BNKL
Transactions as of
13 Jun 2023
Transactions value $
$1,861,727
Form type
4
Filing time
21 Jun 2023, 10:59:27 UTC
Previous filing
21 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNKL Common Stock, par value $0.001 per share Conversion of derivative security $1,861,727 +3,102,878 +171% $0.6000 4,917,749 13 Jun 2023 Shares held through GD Holdings and Lombard International Assurance SA F1, F2
holding BNKL Common Stock, par value $0.001 per share 61,256 13 Jun 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective as of June 13, 2023, an aggregate amount of approximately $5,171,463 of principal and accrued interest in outstanding convertible debt held by GD Holdings converted in accordance with its terms into 3,102,878 shares of the Issuer's common stock.
F2 Includes 17,476 exchangeable shares of the Issuer's subsidiary.